Israeli oncology centers provide multi-modal treatment including high-dose chemotherapy, limb-sparing surgery, and bone marrow transplantation. Facilities like Sheba Medical Center utilize PET/CT imaging and molecular profiling to tailor protocols. Specialized units focus on pediatric cases using advanced techniques like stem cell rescue and CAR-T therapies.
- Surgical precision: Surgeons perform complex limb-sparing resections to preserve functional movement and outcomes.
- Advanced diagnostics: PET/CT imaging and genetic profiling identify EWSR1-FLI1 fusions for targeted therapy.
- Cellular therapy: Bone marrow transplantation is offered for pediatric high-risk or recurrent sarcoma cases.
- Expert consultation: Multidisciplinary teams include oncologists, radiologists, and orthopedic surgeons for integrated care.
Bookimed Expert Insight: While chemotherapy remains the standard, clinics like Sheba and Sourasky differentiate through volume and specialization. Dr. Boaz Liberman at Sheba focuses on functional outcomes using magnetic resonance-guided ultrasound. Sourasky reports a 90% oncology success rate with experts like Dr. Ofer Merimsky. These centers manage high patient volumes, often treating over 1,000,000 people annually.
Patient Consensus: Patients note that Israel offers faster access to experimental treatments and compassionate use drugs compared to many global waitlists. Families emphasize the importance of early genetic testing to ensure eligibility for the newest clinical trials and targeted therapies.